[Transitional cell carcinoma of the ureter and cyclophosphamide: apropos of a case].
The authors present a case of transitional cell carcinoma of the ureter in a patient treated by cyclophosphamide-based chemotherapy and radiotherapy for Hodgkin's disease. In the light of this case, they review the eight previously reported cases of cyclophosphamide-induced ureteric tumours.
Ponsot
Y
Y
Service d'Urologie, Centre Hospitalier Universitaire de Sherbrooke, Québec, Canada.
Guerin
J G
JG
Carmel
M
M
D018906:Antineoplastic Agents, Alkylating / Q000009:adverse effects*; D002273:Carcinogens / Q000009:adverse effects; D002295:Carcinoma, Transitional Cell / Q000473:pathology*; D003520:Cyclophosphamide / Q000009:adverse effects*; D005500:Follow-Up Studies; D006689:Hodgkin Disease / Q000188:drug therapy / Q000532:radiotherapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D016609:Neoplasms, Second Primary / Q000473:pathology*; D014516:Ureteral Neoplasms / Q000473:pathology*
D018906:Antineoplastic Agents, Alkylating; D002273:Carcinogens; D003520:Cyclophosphamide
Carcinome transitionnel de l'uretère et cyclophosphamide: a propos d'un cas.